Al-Ahram Pharmaceutical Conference (APC) Saturday (Photo: Al-Ahram)
Abdel-Ghaffar made these remarks during the second edition of the Al-Ahram Pharmaceutical Conference (APHC), held on October 16 and 17 under the high patronage of Prime Minister Moustafa Madbouly, the presidency of Mahmoud El-Metini, the president of Ain Shams University, and honorary presidency of Ashraf Hatem, chairman of the parliamentary health committee.
Presenting practical solutions to the challenges facing the Egyptian pharmaceutical industry, during the nine sessions of the conference, Minister of Finance Mohamed Maait, Minister of Higher Education Abdel-Ghaffar, Presidential Advisor for Health Affairs Mohamed Awad Tageddin, governors, officials and representatives of pharmaceutical and medical supply companies in Egypt and abroad.
During the opening speech, the chairman of the board of directors of the establishment Al-Ahram Abdel-Mohsen Salama said that President Abdel-Fattah El-Sisi said that Egypt would be a regional hub for manufacturing drugs.
The mega pharmaceutical city inaugurated by Egypt is essential for providing quality treatment to Egyptians from all walks of life and exporting medicines to Africa and the Middle East through cooperation with international companies, added Salama.
Al-Ahram editor-in-chief AlaaThabet said the Egyptians had aspired to localize the pharmaceutical industry for decades. “The pharmaceutical sector is vital” to the national economy, he said.
Tageddin, for his part, praised Al-Ahram’s role in organizing the APHC at a time when the coronavirus pandemic is wreaking havoc around the world, wreaking havoc in the economic, financial and health sectors. of each country.
During the conference, Tageddin reviewed Egyptian efforts to curb the spread of the coronavirus, saying Egypt had taken preventative measures to contain the crisis.
Tamer Essam, chairman of the Egyptian Medicines Authority, said Egypt is laying the groundwork for a pharmaceutical sector strategy aimed primarily at delivering quality treatment to Egyptians.
Egypt’s Vision 2030 includes a comprehensive set of plans for better infrastructure, roads, utilities, legislation and media, Essam added, stressing the need for investors and industry to formulate a vision to implement projects that contribute to the growth of Egypt.
Bahaaeddin Zeidan, the chairman of the Egyptian Authority for Unified Procurement, said on the first day of the conference that Egypt has taken concrete steps to locate the pharmaceutical industry, including forming a committee comprising all relevant authorities to establish a roadmap for mass production of drugs in Egypt. The strategy will be based on the vision of political leadership to overhaul the health system in the country and cooperate with regional and international entities to this end.
Hatem, of the parliamentary health committee, said the first edition of the APHC, held in 2019, was the main reason for the enactment of Law 214 on clinical trials last year, stressing that the law would enter in force once its executive regulations are published.
The first edition of the pharmaceutical conference formed a committee to monitor the implementation of its work program, vision and recommendations in cooperation with the Egyptian Ministry of Health.
In addition, the Standing Committee of Conference Participants submitted the recommendations of the first edition to the authorities concerned who have been tasked with monitoring their implementation in the framework of continuous dialogue and interaction between all parties concerned. .
The Standing Committee plans to work on implementing the recommendations of the second edition in a similar fashion.